SCHEMBL29132997

SCHEMBL29132997

COCc1ncccc1Br.NNC=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
NPC1 O15118 3/20 0.33
HTT P42858 3/20 0.33
RAB9A P51151 3/20 0.33
KDM4E B2RXH2 2/20 0.33
ALOX12 P18054 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
P2RX7 Q99572 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.32
ALDH1A1 P00352 3/20 0.32
POLB P06746 2/20 0.32
MAPT P10636 1/20 0.32
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
SYK P43405 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ABL1 P00519 1/20 0.31
HKDC1 Q2TB90 1/20 0.31
PADI1 Q9ULC6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15845985 0.86 NPC1 (0.40) NPC1HTTRAB9AKDM4EALOX12
SCHEMBL29133119 0.77 HTR2A (0.40) TRIM24TRIM33ALDH1A1HTR2AHTR2C
SCHEMBL28102228 0.74 TRIM24 (0.39) TRIM24TRIM33NPC1HTTRAB9A
SCHEMBL27987069 0.71 TRIM24 (0.47) TRIM24TRIM33NPC1HTTRAB9A
SCHEMBL29132983 0.71 TRIM24 (0.43) TRIM24TRIM33NPC1HTTRAB9A
SCHEMBL657873 0.71 ADH1B (0.41) TRIM24TRIM33NPC1RAB9AKDM4E
SCHEMBL4106646 0.70 TRIM24 (0.44) TRIM24TRIM33NPC1HTTRAB9A
SCHEMBL24107663 0.69 ALDH1A1 (0.44) KDM4ESMN1; SMN2ALDH1A1SYKL3MBTL1
SCHEMBL29587068 0.69 AKT1 (0.34) NPC1RAB9ASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL398730 0.69 AKT1 (0.34) NPC1RAB9ASMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117088884-A Imidazopyridazine derivatives as GABAA receptor modulators, pharmaceutical compositions and uses 上海赛默罗德生物科技有限公司 2023-11-21 CN disclosed